We are live on !
Find out more
Bleichroeder Portfolio holdings
AUM
$1.02B
Turnover
33.63%
1-Year Est. Return
33%
This Fund
S&P 500
This Quarter Est. Return
-1.54%
1 Year Est. Return
+33%
3 Year Est. Return
+222.49%
5 Year Est. Return
+219.92%
10 Year Est. Return
–
AUM
$479M
AUM Growth
-$5.04M
(-1%)
Cap. Flow
+$8.34M
Cap. Flow % of AUM
Cap. Flow %
1.74%
Top 10 Holdings %
Top 10 Hldgs %
67.05%
Holding
98
New
1
Increased
4
Reduced
1
Closed
5
Avg Time Held
1.7
years
Top 10 Avg Time Held
1.5
years
Top 20 Avg Time Held
1.6
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ProKidney
PROK
|
+$17.4M |
| 2 |
GPGI Inc
GPGI
|
+$3.2M |
| 3 |
TCDA
Tricida, Inc. Common Stock
TCDA
|
+$547K |
| 4 |
Ondas Inc
ONDS
|
+$436K |
| 5 |
LiqTech
LIQT
|
+$267K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ISLE
Isleworth Healthcare Acquisition Corporation Common stock
ISLE
|
+$10M |
| 2 |
FAZE
FaZe Holdings Inc. Common Stock
FAZE
|
+$2.24M |
| 3 |
TEKK
Tekkorp Digital Acquisition Corp. Class A Ordinary Shares
TEKK
|
+$990K |
| 4 |
SaverOne 2014 Ltd
SVRE
|
+$272K |
| 5 |
CTIC
CTI BioPharma Corp. (DE) Common Stock
CTIC
|
+$31.2K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 23.49% |
| 2 | Consumer Discretionary | 16.65% |
| 3 | Miscellaneous | 15.6% |
| 4 | Industrials | 15.31% |
| 5 | Financials | 13.16% |
Similar funds
KL
Bleichroeder's Q3 2022 Portfolio in Review
As of Q3 2022, Bleichroeder held 98 positions worth $479M, down 1% from $484M the previous quarter. Its ten largest holdings account for 67% of the portfolio.
Bleichroeder's Q3 2022 filing shows 1 new, 4 increased, 1 reduced and 5 closed positions. Its largest new stake was ProKidney: 2,000,000 shares worth $18M. The largest sale was Isleworth Healthcare Acquisition Corporation Common stock, an estimated $10M.
By sector, the portfolio is most concentrated in Healthcare at 23% of assets, up from 19% a quarter earlier, followed by Consumer Discretionary and Miscellaneous.
- Bleichroeder's largest Q3 2022 buy was ProKidney: 2,000,000 shares worth $18M.
- Bleichroeder added most to GPGI Inc in Q3 2022, an estimated $3.2M increase.
- Bleichroeder's biggest Q3 2022 reduction was CTI BioPharma Corp. (DE) Common Stock, cutting an estimated $31.2K.
- Bleichroeder fully exited Isleworth Healthcare Acquisition Corporation Common stock in Q3 2022, selling an estimated $10M.
- Bleichroeder's ten largest holdings make up 67% of its $479M portfolio in Q3 2022.
- Bleichroeder opened 1 new position and closed 5 in Q3 2022.
- Bleichroeder's portfolio value fell 1% quarter-over-quarter to $479M.
Based on Bleichroeder's 13F filing for Q3 2022, filed 14 Nov 2022.